Esperion Therapeutics, Inc.
ESPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $92,447 | $86,061 | $114,633 | $144,761 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $118,980 | $107,746 | $81,294 | $80,142 |
| Inventory | $141,838 | $114,466 | $99,322 | $94,491 |
| Other Curr. Assets | $7,199 | $34,322 | $23,529 | $18,604 |
| Total Curr. Assets | $360,464 | $342,595 | $318,778 | $337,998 |
| Property Plant & Equip (Net) | $3,500 | $4,434 | $5,195 | $5,767 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $56 | $56 | $56 | $56 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $3,556 | $4,490 | $5,251 | $5,823 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $364,020 | $347,085 | $324,029 | $343,821 |
| Liabilities | – | – | – | – |
| Payables | $77,513 | $74,704 | $71,994 | $51,650 |
| Short-Term Debt | $152,073 | $123,816 | $57,492 | $57,316 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4,542 | $8,518 |
| Other Curr. Liab. | $129,447 | $100,276 | $136,938 | $128,749 |
| Total Curr. Liab. | $359,033 | $298,796 | $270,966 | $246,233 |
| LT Debt | $448,912 | $474,362 | $240,292 | $240,286 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7,436 | $7,436 | $238,982 | $246,024 |
| Total NC Liab. | $456,348 | $481,798 | $479,274 | $486,310 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3,151 | $4,050 | $4,794 | $5,311 |
| Total Liabilities | $815,381 | $780,594 | $750,240 | $732,543 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $205 | $200 | $197 | $196 |
| Retained Earnings | -$1,685,542 | -$1,654,209 | -$1,641,484 | -$1,601,029 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $1,233,976 | $1,220,500 | $1,215,076 | $1,212,111 |
| Total Equity | -$451,361 | -$433,509 | -$426,211 | -$388,722 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $364,020 | $347,085 | $324,029 | $343,821 |
| Net Debt | $508,538 | $512,117 | $183,151 | $152,841 |